A Study to Determine the Tolerability and Pharmacokinetics for Ropinirole in Paediatric / Adolescent Patients With RLS (Type 2)
Phase of Trial: Phase I
Latest Information Update: 13 Sep 2017
At a glance
- Drugs Ropinirole (Primary)
- Indications Restless legs syndrome
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 07 Nov 2008 Status changed from recruiting to completed.
- 15 Oct 2008 Actual start date changed from Nov 2004 to Jun 2005 as reported by Clinicaltrials.gov
- 26 Nov 2007 Added trial centre.